TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression.
C ZengY ZhangC LinW LiangJ ChenY ChenH XiaoY LiHongyu GuanPublished in: Journal of endocrinological investigation (2024)
Our results suggest that TFCP2L1 is a tumor suppressor and potential differentiation regulator, and might be a potential therapeutic target in thyroid cancer.